INTECH Investment Management’s Janux Therapeutics JANX Stock Holding History

INTECH Investment Management’s Portfolio JANX Stock Details JANX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$176K	Buy	11,473 +73	+0.6%	+$1.06K	﹤0.01%	1821
2026 Q1	$158K	Sell	11,400 -5,343	-32%	-$73.3K	﹤0.01%	1808
2025 Q4	$231K	Hold	16,743	–	–	﹤0.01%	1901
2025 Q3	$409K	Sell	16,743 -5,192	-24%	-$126K	﹤0.01%	1676
2025 Q2	$507K	Buy	21,935 +3,051	+16%	+$80.4K	﹤0.01%	1606
2025 Q1	$510K	Buy	18,884 +10,614	+128%	+$400K	0.01%	1605
2024 Q4	$443K	Buy	8,270 +162	+2%	+$8.57K	﹤0.01%	1630
2024 Q3	$368K	Buy	+8,108	New	+$353K	﹤0.01%	1395

Other funds holding JANX

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

INTECH Investment Management's JANX Position: Q2 2026 in Review

INTECH Investment Management increased its Janux Therapeutics (JANX) stake by 0.64% in Q2 2026, buying an estimated $1.06K and bringing the position to 11,473 shares worth $176K. The position accounts for ﹤0.01% of the portfolio, ranked #1821.

INTECH Investment Management first reported a position in JANX in Q3 2024 and has held it in 8 quarters since. The position peaked at $510K in Q1 2025. 198 funds tracked by Wall St. Rank hold JANX as of Q2 2026.

INTECH Investment Management held 11,473 shares of Janux Therapeutics worth $176K as of Q2 2026.
INTECH Investment Management bought 73 Janux Therapeutics shares in Q2 2026, an estimated $1.06K.
Janux Therapeutics made up ﹤0.01% of INTECH Investment Management's portfolio in Q2 2026, its #1821 holding.
INTECH Investment Management first reported a position in Janux Therapeutics in Q3 2024 and has held it in 8 quarters since.
INTECH Investment Management's Janux Therapeutics position peaked at $510K in Q1 2025.
198 funds tracked by Wall St. Rank held Janux Therapeutics as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.